Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca
Clinical trial NCT00128245 · COMPLETED
Trial details
- NCT number
- NCT00128245
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2006-12-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.